Literature DB >> 2850314

Autonomic dysfunction and adrenocortical unresponsiveness to ACTH.

G Makari1, W H Hoffman, J E Carroll, D R Savage, T Van der Zalm.   

Abstract

A child is reported with adrenocortical unresponsiveness to ACTH and autonomic dysfunction. The latter consisted of cold extremities, progressive loss of tear production, the development of achalasia of the esophagus, pupillary dysfunction, and an abnormal histamine skin test. These findings suggest progressive parasympathetic denervation as a cause for the adrenocortical abnormality.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850314     DOI: 10.1177/088307388800300304

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  5 in total

1.  Neurological and adrenal dysfunction in the adrenal insufficiency/alacrima/achalasia (3A) syndrome.

Authors:  D B Grant; N D Barnes; M Dumic; M Ginalska-Malinowska; P J Milla; W von Petrykowski; R J Rowlatt; R Steendijk; J H Wales; E Werder
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

2.  Allgrove'S syndrome: case report and literature review.

Authors:  Mohamed I Yasawy
Journal:  J Family Community Med       Date:  2009-01

3.  AAA Syndrome, Case Report of a Rare Disease.

Authors:  S Waqar H Shah; Arshad K Butt; K Malik; Altaf Alam; Adnan Shahzad; Anwaar A Khan
Journal:  Pak J Med Sci       Date:  2017 Nov-Dec       Impact factor: 1.088

4.  Longitudinal neuropsychological profile in a patient with triple a syndrome.

Authors:  Luigi Mazzone; Valentina Postorino; Lavinia De Peppo; Lia Vassena; Laura Fatta; Marco Armando; Giuseppe Scirè; Marco Cappa; Stefano Vicari
Journal:  Case Rep Pediatr       Date:  2013-04-09

5.  Triple-A syndrome with prominent ophthalmic features and a novel mutation in the AAAS gene: a case report.

Authors:  Brian P Brooks; Robert Kleta; Rafael C Caruso; Caroline Stuart; Jonathan Ludlow; Constantine A Stratakis
Journal:  BMC Ophthalmol       Date:  2004-06-24       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.